Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

Trump could keep Biden’s commitment to have Medicare pay for weight loss drugs such as Ozempic and Wegovy. But would ...

Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...

According to a 2018 study, there were no safety concerns for semaglutide prescription medication treatments for weight loss. Semaglutide medications include Wegovy and Ozempic. Additionally, 2022 ...

When used correctly, prescription weight-loss medications provide people battling severe weight management problems with life-changing -- and, in some cases, life-saving -- health benefits.

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

Weight loss injections are administered with a needle under the skin. Some injectable prescription medications, like liraglutide (Saxenda®) and tirzepatide (Zepbound® and Mounjaro®), support ...

Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending ...

The research shows the percentage of adults with obesity dropped from 46% in 2022 ... prescription rates for these medications, showed notable improvements in obesity rates. ExploreOzempic, weight ...